LINC01742

Across TCGA pan-cancer cohorts, LINC01742 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01742’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01742 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01742 is over-expressed in tumor.

BRCA, COAD, and STAD are the cancer types where LINC01742 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01742 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.064	<.001	4	view →
COAD	All	All	+0.043	.039	1	view →
STAD	All	II,III,IV	+0.022	.048	1	view →
LUSC	All	All	+0.021	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC01742–BRCA

Open the BRCA breakdown →